Imatinib (IM) and Interferon-Alpha (IFN-a) Maintenance Therapy Is Associated with Long-Term DFS in a Subset of Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)

被引：2
|
作者：
Pfeifer, Heike [1 ]
Wystub, Sylvia [2 ]
Binckebanck, A. [1 ]
Wassmann, Barbara
Kaebisch, Andreas
Luebbert, Michael [3 ]
Leimer, Lothar [4 ]
Giagounidis, Aristoteles [5 ]
Gassmann, Winfried [6 ]
Brueck, Patrick [2 ]
Serve, Hubert [1 ]
Hoelzer, Dieter [7 ]
Ottmann, Oliver G. [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Med, D-60054 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Dept Hematol, D-60054 Frankfurt, Germany
[3] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany
[4] Robert Bosch Krankenhaus, Stuttgart, Germany
[5] St Johannes Hosp, Med Klin 2, Duisburg, Germany
[6] St Marien Krankenhaus gGmbH, Siegen, Germany
[7] Goethe Univ Hosp, Dept Internal Med Hematol & Oncol 2, Frankfurt, Germany
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1503.1503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1503
引用
收藏
页数：2
相关论文
共 50 条
  • [1] THE LONG-TERM OUTCOME OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL) IN THE IMATINIB ERA
    Delannoy, A.
    Delabesse, E.
    Lheritier, V.
    Castaigne, S.
    Rigal-Huguet, F.
    Raffoux, E.
    Garban, F.
    Legrand, O.
    Bologna, S.
    Dubruille, V.
    Turlure, P.
    Reman, O.
    Delain, M.
    Isnard, F.
    Coso, D.
    Raby, P.
    Buzyn, A.
    Cailleres, S.
    Darre, S.
    Fohrer, C.
    Sonet, A.
    Bilhou-Nabera, C.
    Bene, M. -C.
    Dombret, H.
    Thomas, X.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 30 - 31
  • [2] Imatinib and Interferon-Alpha Maintenance Therapy for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Ineligible for Allogeneic Stem Cell Transplantation (SCT).
    Pfeifer, Heike
    Wassmann, Barbara
    Kaebisch, Andreas
    Luebbert, Michael
    Leimer, Lothar
    Giagounidis, Aristoteles
    Hoelzer, Dieter
    Ottmann, Oliver G.
    BLOOD, 2009, 114 (22) : 806 - 806
  • [3] Long-term imatinib maintenance therapy for adult Philadelphia positive acute lymphoblastic leukemia
    Guillet, Stephanie
    Hirsch, Pierre
    Marzac, Christophe
    Mohty, Mohamad
    Marie, Jean-Pierre
    Legrand, Ollivier
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2646 - 2648
  • [4] Long term follow up of elderly patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph plus ALL): Updated results of the GMALL elderly trials
    Pfeifer, H.
    Wystub, S.
    Voelp, C.
    Wassmann, B.
    Brueck, P.
    Giagounidis, A.
    Stelljes, M.
    Duehrsen, U.
    Schmalzing, M.
    Schaich, M.
    de Wit, M.
    Ganser, A.
    Fritsch, G.
    Gassmann, W.
    Pfreundschuh, M.
    Mueller, M.
    Wendelin, K.
    Schmid, M.
    Beck, H-J
    Dengler, J.
    Horst, H. A.
    Luebbert, M.
    Serve, H.
    Hoelzer, D.
    Ottmann, O.
    ONKOLOGIE, 2010, 33 : 212 - 212
  • [5] Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Pfeifer, Heike
    Goekbuget, Nicola
    Voelp, Christian
    Huettmann, Andreas
    Luebbert, Michael
    Stuhlmann, Reingard
    Dengler, Julanta
    Kreuzer, Karl-Anton
    Beck, Joachim
    Stelljes, Matthias
    Schmid, Mathias
    Wassmann, B.
    Leimer, Lothar
    Spiekermann, Karsten
    Terwey, Theis E.
    Schaefer-Eckart, K.
    Ditz, D.
    Lindemann, H.
    Morgner, A.
    Schaich, Markus
    Burmeister, Thomas
    Binckebanck, A.
    Hoelzer, Dieter
    Ottmann, Oliver G.
    BLOOD, 2010, 116 (21) : 79 - 79
  • [6] LONG TERM FOLLOW UP OF ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA (PH plus ALL): UPDATED RESULTS OF THE GMALL ELDERLY TRIALS
    Pfeifer, H.
    Wettner, C.
    Wassmann, B.
    Giagounidis, A.
    Stelljes, M.
    Duehrsen, U.
    Schmalzing, M.
    Schaich, M.
    De Wit, M.
    Ganser, A.
    Gassmann, W.
    Pfreundschuh, M.
    Haertel, N.
    Wendelin, K.
    Schmid, M.
    Beck, H. J.
    Dengler, J.
    Horst, H. A.
    Luebbert, M.
    Serve, H.
    Goekbuget, N.
    Hoelzer, D.
    Ottmann, O.
    HAEMATOLOGICA, 2012, 97 : 463 - 463
  • [7] Treatment outcome with imatinib-based maintenance therapy in elderly patients with Philadelphia-positive acute lymphoblastic leukaemia (Ph plus ALL) ineligible for allogeneic stem cell transplantation (SCT)
    Pfeifer, Heike
    Wassmann, Barbara
    Wystub, Sylvia
    Wunderle, Lydia
    Chromik, Joerg
    Brueck, Patrick
    Hochhaus, Andreas
    Binckebanck, Anja
    Hoelzer, Dieter
    Ottmann, Oliver
    BLOOD, 2007, 110 (11) : 829A - 829A
  • [8] Long-lasting response in patients with Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) treated with imatinib mesylate (Glivec, STI-571)
    Martinez, J
    de la Rubia, J
    Martin, G
    Sanz, G
    Cervera, J
    Pérez-Sirvent, M
    Lorente, P
    Linares, D
    Jarque, I
    Lorenzo, I
    Sanz, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S179 - S180
  • [9] Short Chemotherapy-Phased Imatinib (IM) Pulses Improve Long-Term Outcome of Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Bassan, Renato
    Rossi, Giuseppe
    Pogliani, Enrico Maria
    Di Bona, Eros
    Angelucci, Emanuele
    Cavattoni, Irene
    Cortelezzi, Agostino
    Gianfaldoni, Giacomo
    Levis, Alessandro
    Ciceri, Fabio
    Mattei, Daniele
    Borlenghi, Erika
    Terruzzi, Elisabetta
    Borghero, Carlo
    Romani, Claudio
    Spinelli, Orietta
    Tosi, Manuela
    Oldani, Elena
    Intermesoli, Tamara
    Rambaldi, Alessandro
    BLOOD, 2009, 114 (22) : 801 - 801
  • [10] IMATINIB MAINTENANCE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE (PH plus ) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Kebriaei, P.
    Chiattone, A.
    Saliba, R.
    Jones, D.
    Anderlini, P.
    Andersson, B.
    Khouri, I
    Worth, L.
    Ravandi, F.
    Thomas, D.
    Kantarjian, H.
    Hamerschlak, N.
    Rodrigues, M.
    de Lima, M.
    Giralt, S.
    Champlin, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S230 - S230
12345